Clinical and Sociodemographic Factors Associated with Cognitive Impairment and Neuroprotection in Diabetes Patients

  1. Valiente Barroso, Carlos
  2. Alvarado Izquierdo, Jesús María
  3. García García, Emilio
Revista:
The Spanish Journal of Psychology

ISSN: 1138-7416

Año de publicación: 2015

Volumen: 18

Tipo: Artículo

DOI: 10.1017/SJP.2015.61 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: The Spanish Journal of Psychology

Resumen

The aim of this study is to analyze the potential impact of factors (clinical and demographic variables and comorbidities) associated with Diabetes Mellitus (DM) on certain mental processes related to cognitive impairment, with special attention to the analysis of parameters that define processing speed and executive function. Neuropsychological examination of elderly Spanish patients (N = 59, 33 females, Mage 70.98 years) diagnosed with DM, in addition to application of an ad hoc questionnaire to collect information on comorbidities and other relevant demographic variables. Based on a cross-sectional design, correlational analysis was carried out. Cognitive performance showed an inverse relationship to age and cardiopathology while years of schooling and regular physical activity appeared as neuroprotective factors. DM is an illness which, linked to other variables, can be regarded as a risk factor for the development of cognitive impairment. Certain factors (physical activity and cognitive stimulation) have the potential to mitigate this tendency. There is a need to further our understanding of the neurobiological mechanisms involved.

Referencias bibliográficas

  • Acee A. M. (2012). Type 2 diabetes and vascular dementia: Assessment and clinical strategies of care. Medsurg Nursing, 21, 349–353.
  • Akisaki T., Sakurai T., Takata T., Umegaki H., Araki A., Mizuno S., … Ito H. (2006). Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes
  • intervention trial (J-EDIT). Diabetes/Metabolism Research and Reviews, 22, 376–384. http://dx.doi.org/10.1002/dmrr.632
  • Allen K. V., Frier B. M., & Strachan M. W. (2004). The relationship between type 2 diabetes and cognitive dysfunction: Longitudinal studies. European Journal of Pharmacology, 490, 169–175.
  • Andel R., Vigen C., Mack W. J., Clark L. J., & Gatz M. (2006). The effect of education and occupational complexity on rate of cognitive decline in alzheimer’s patients. Journal of the International Neuropsychological Society, 12, 147–152.
  • Ardila A., & Rosselli M. (2007). Neuropsicología clínica [Clinical neuropsychology]. Mexico DF, Mexico: Manual Moderno.
  • Arvanitakis Z., Wilson R. S., Bienias J. L., Evans D. A., & Bennet D. A. (2004). Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Archives of Neurology, 61, 661–666. http://dx.doi.org/10.1001/archneur.61.5.661
  • Baker L. D., Frank L. L., Foster-Schubert K., Green P. S., Wilkinson C. W., McTiernan A., … Craft S. (2010). Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease. Journal of Alzheimer's Disease, 22, 569–579. http://dx.doi.org/10.3233/JAD-2010-100768
  • Beydoun M. A., Beydoun H. A., & Wang Y. (2008). Obesity and central obesity as risk factors for incident dementia and its subtypes: A systematic review and meta-analysis. Obesity Reviews, 9, 204–218. http://dx.doi.org/10.1111/j.1467-789X.2008.00473.x
  • Beisiegel U., & Spector A. A. (2001). Lipids and lipoproteins in the brain. Current Opinion in Lipidology, 12, 243–244. http://dx.doi.org/10.1097/00041433-200106000-00001
  • Biessels G. J., Deary I. J., & Ryan C. M. (2008). Cognition and diabetes: A life-span perspective. The Lancet Neurology, 7, 184–190. http://dx.doi.org/10.1016/S14744422(08)70021-8
  • Borroni B., Premi E., Bozzali M., & Padovani A. (2012). Reserve mechanisms in neurodegenerative diseases: From bench to bedside and back again. Current Medicinal Chemistry, 19, 6112–6118. http://dx.doi.org/10.2174/092986712804485737
  • Bruce D. G., Davis W. A., Casey G. P., Starkstein S. E., Clarnette R. M., Almeida O. P., & Davis T. M. E. (2008). Predictors of cognitive decline in older individuals with diabetes. Diabetes Care, 31, 2103–2107. http://dx.doi.org/10.2337/dc08-0562
  • Bruehl H., Rueger M., Dziobek I., Sweat V., Tirsi A., Javier E., … Convit A. (2007). Hypo-thalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism, 92, 2439–2445.
  • Cai A., Li L., Zhang Y., Mo Y., Mai W., & Zhou Y. (2013). Lipoprotein(a): A promising marker for residual cardiovascular risk assessment. Disease Markers, 35, 551–559. http://dx.doi.org/10.1155/2013/563717
  • Cukierman T., Gerstein H. C., &Williamson J. D. (2005). Cognitive decline and dementia in diabetes-systematic overview of prospective studies. Diabetologia, 48, 2460– 2469. http://dx.doi.org/10.1007/s00125-005-0023-4
  • Cukierman-Yaffe T. (2009). Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: The action to control cardiovascular risk in diabetes memory in diabetes (ACCORD-MIND) trial. Diabetes Care, 32, e103. http://dx.doi.org/10.2337/dc09-0821
  • CIBERDEM. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (2013). Estudio di@betes. [Diabetes Study]. Madrid, Spain: Centro de Investigación Biomédica en Red (CIBER) Instituto de Salud Carlos III. Retrieved from http://www.ciberdem.org/estudio_diabetes.php
  • Danaei G., Finucane M. M., Lu Y., Singh G. M., Cowan M. J., Paciorek C. J., … Ezzati M. (2011). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. The Lancet, 378, 31–40. http://dx.doi.org/10.1016/S0140-6736(11)60679-X
  • Dasgupta K., Khan S., & Ross N. A. (2010). Type 2 diabetes in Canada: Concentration of risk among most disadvantaged men but inverse social gradient across groups in women. Diabetic Medicine, 27, 522–531. http://dx.doi.org/10.1111/j.1464-5491.2010.02982.x
  • De Melo M., de Sa E., & Gucciardi E. (2013). Exploring differences in Canadian adult men and women with Diabetes management: Results from the Canadian community health survey. BMC Public Health, 13, 1089. http://dx.doi.org/10.1186/1471-2458-13-1089
  • Diamond A. (2002). Normal development of prefrontal cortex from birth to young adulyhood: Cognitive function, anatomy and biochemistry. In D. T. Stuss, & R. T. Knight (Eds.). Principles of frontal lobes function. London, UK: Oxford University Press.
  • Folstein M., Folstein S. E., & McHugh P. R. (1975). “Mini-Mental State” a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198. http://dx.doi.org/10.1016/0022-3956(75)90026-6
  • Foster P. P., Rosenblatt K. P., & KuljiÅ¡ R. O. (2011). Exercise induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's disease. Frontiers in Neurology, 2, 28. http://dx.doi.org/10.3389/fneur.2011.00028
  • Franco-Martín M., Parra-Vidales E., González-Palau F., Bernate-Navarro M., & Solis A. (2013). Influencia del ejercicio físico en la prevención del deterioro cognitivo en las personas mayores: Revisión sistemática [The influence of physical exercise in the prevention of cognitive deterioration in the elderly:A systematic review]. Revista de Neurología, 56, 545–554.
  • Fratiglioni L., & Wang H. X. (2007). Brain reserve hypothesis in dementia. Journal of Alzheimer’s Disease, 12, 11–22.
  • Freeman L. R., Haley-Zitlin V., Rosenberger D. S., & Granholm A. C. (2014). Damaging effects of a high-fat diet to the brain and cognition: A review of proposed mechanisms. Nutritional Neuroscience, 17, 241–251. http://dx.doi.org/10.1179/1476830513Y.0000000092
  • Gazdzinski S., Kornak J., Weine M. W., & Meyerhoff D. J. (2008). Body mass index and magnetic resonance markers of brain integrity in adults. Annals of Neurology, 34, 2089–2096. http://dx.doi.org/10.1111/j.1530-0277.2010.01305.x
  • Gioia G. A., Isquith P. K., Guy S. C., & Kenworthy L. (2000). Behavior rating inventory of executive function. Neuropsychology, Development, and Cognition. Section C, Child Neuropsychology, 6, 235–238.
  • Golden J. C. (1994). Stroop. Test de colores y palabras [Stroop color–word Test]. Madrid, Spain: TEA.
  • Graham N. L., Emery T., & Hodges J. R. (2005). Distinctive cognitive profile in Alzheimer’s diseases and subcortical vascular dementia. Journal of Neurology, Neurosurgery & Psychiatry, 75, 61–71.
  • Gunstad J., Paul R. H., Cohen R. A., Tate D. F., Spitznagel M. B., & Gordon E. (2007). Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Comprehensive Psychiatry, 48, 57–61. http://dx.doi.org/10.1016/j.comppsych.2006.05.001
  • Haninen T., Koivisto K., Reinikainen K. J., Vanhanen M., Helkala E. L., Soininen H., … Riekkinen P. J. (1996). Prevalence of age-associated cognitive decline in an elderly population. Age and Ageing, 25, 201–205.
  • Ho N., Sommers M. S., & Lucki I. (2013). Effects of diabetes on hippocampal neurogenesis: Links to cognition and depression. Neuroscience & Biobehavioral Reviews, 37, 1346–1362. http://dx.doi.org/10.1016/j.neubiorev.2013.03.010
  • Hughes T. M., Lopez O. L., Evans R. W., Kamboh M. I., Williamson J. D., Klunk W. E., … Kuller L. H. (2014). Markers of cholesterol transport are associated with amyloid deposition in the brain. Neurobiology Aging, 35, 802–807. http://dx.doi.org/10.1016/j.neurobiolaging.2013.09.040
  • Jacobson A. M., Musen G., Ryan C. M., Silvers N., Cleary P., Waberski B., … Harth J. (2007). Diabetes control and complications trial/epidemiology of diabetes interventions and complications study research group. Long-term effect of diabetes and its treatment on cognitive function. The New England Journal of Medicine, 356, 1842–1852.
  • Jarvik G. P., Wijsman E. M., Kukull W. A., Schellenberg G. D., Yu C., & Larson E. B. (1995). Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction for Alzheimer’s disease: A case-control study. Neurobiology, 45, 1092–1096.
  • Jeong S. K., Nam H. S., Son M. H., Son E. J., & Cho K. H. (2005). Interactive effect of obesity indexes on cognition. Dementia and Geriatric Cognitive Disorders, 19, 91–96. http://dx.doi.org/10.1159/000082659
  • Joosten H., van Eersel M. E., Gansevoort R. T., Bilo H. J., Slaets J. P., & Izaks G. J. (2013). Cardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjects. Stroke, 44, 1543–1549. http://dx.doi.org/10.1161/STROKEAHA.111.000496
  • Kalmijn S., Foley D., White L., Burchfiel C. M., Curb J. D., Peteovitch H., … Launer L. J. (2000). Metabolic cardiovascular syndrome and risk of dementia in Japanese American elderly men: The Honolulu Asia Aging Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 2255–2560. http://dx.doi.org/10.1161/01.ATV.20.10.2255
  • Katon W. J., Lin E. H., Williams L. H., Ciechanowski P., Heckbert S. R., Ludman E., … Von Korff M. (2010). Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: A prospective cohort study. Journal of General Internal Medicine, 25, 423–429. http://dx.doi.org/10.1007/s11606-009-1248-6
  • Knopman D. S., Mosley T. H., Catellier D. J., & Sharrett A. R. (2005). Atherosclerosis Risk in Communities (ARIC) Study. Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort. Neurology, 65, 876–881.
  • Lezak M. D. (1982). The problem of assessing executive functions. International Journal of Psychology, 17, 281–297. http://dx.doi.org/10.1080/00207598208247445
  • Luria A. R. (1969). Frontal lobe syndromes. In P. J. Vinken & G. W. Bruyn. (Eds.). Handbook of clinical neurology, (Vol. 2., pp. 725–757). Amsterdam, the Netherlands: North Holland.
  • Manschot S. M., Brands A. M., van der Grond J., Kessels R. P., Algra A., Kappelle, … Biessels G. J. (2006). Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes, 55, 1106–1113.
  • McFall G. P., Wiebe S. A., Vergote D., Westaway D., Jhamandas J., & Dixon R. A. (2013). IDE (rs6583817) polymorphism and type 2 diabetes differentially modify executive function in older adults. Neurobiology of Aging, 34, 2208–2216. http://dx.doi.org/10.1016/j.neurobiolaging.2013.03.010
  • Mejía-Arango S., & Zúñiga-Gil C. (2011). Diabetes mellitus como factor de riesgo de demencia en la población adulta mayor mexicana [Diabetes Mellitus as a risk factor for dementia in the Mexican elder population]. Revista de Neurología, 53, 397–405.
  • Nithianantharaiah J., & Hannan A. J. (2011). Mechanisms mediating brain and cognitive reserve: Experience dependent neuroprotection and functional compensation in animal models of neurodegenerative diseases. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 331–339. http://dx.doi.org/10.1016/j.pnpbp.2010.10.026
  • Obisesan T. O. (2009). Hypertension and cognitive function. Clinics in Geriatric Medicine, 25, 259–288. http://dx.doi.org/10.1016/j.cger.2009.03.002
  • Obisesan T. O., Obisesan O. A., Martins S., Alamgir L., Bond V., Maxwell C, & Gillum R. F. (2008). High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: The third national health and nutrition examination survey. Journal of the American Geriatrics Society, 56, 501–509. http://dx.doi.org/10.1111/j.1532-5415.2007.01592.x
  • Ott A., Stolk R. P., van Harskamp F., Po H. A. P., Hofman A., & Breteler M. M. B. (1999). Diabetes mellitus and the risk of dementia. The Rotterdam Study. Neurology, 53, 1937–1942. http://dx.doi.org/10.1212/WNL.53.9.1937
  • Pannacciulli N., Del Parigi A., Che K., Le D. S., Reiman E. M., & Tataranni P. A. (2006). Brain abnormalities in human obesity: A voxel-based morphometric study. Neuroimage, 31, 1419–1425. http://dx.doi.org/10.1016/j.neuroimage.2006.01.047
  • Ravona-Springer R., Luo X., Schmeidler J., Wysocki M., Lesser G. T., Rapp M. A., … Beeri M. S. (2011). The association of age with rate of cognitive decline in elderly individuals residing in supporting care facilities. Alzheimer Disease and Associated Disorders, 25, 312–316. http://dx.doi.org/10.1097/WAD.0b013e31820d880e
  • Reitan R. M., & Wolfson D. (1985). The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation. Tucson, AZ: Neuropsychology Press.
  • Reitz C., Tang M. X., Manly J., Mayeux R., & Luchsinger J. A. (2007). Hypertension and the risk of mild cognitive impairment. Archives of Neurology, 64, 1734–1740. http://dx.doi.org/10.1001/archneur.64.12.1734
  • Rönnemaa E., Zethelius B., Sundelöf J., Sundström J., Degerman-Gunnarsson M., Berne C., … Kilander L. (2008). Impaired insulin secretion increases the risk of Alzheimer disease. Neurology, 71, 1065–1071. http://dx.doi.org/10.1212/01.wnl.0000310646.32212.3a
  • Ryan C. M., & Geckle M. O. (2000). Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. Diabetes Care, 23, 1486–1493. http://dx.doi.org/10.2337/diacare.23.10.1486
  • Sanz C., Gautier J. F., & Hanaire H. (2010). Physical exercise for the prevention and treatment of type 2 diabetes. Diabetes & Metabolism, 36, 346–351. http://dx.doi.org/10.1016/j.diabet.2010.06.001
  • Shindo A., Terada S., Sato S., Ikeda C., Nagao S., Oshima E., … Uchitomi Y. (2013). Trail making test part a and brain perfusion imaging in Mild Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders Extra, 3, 202–211. http://dx.doi.org/10.1159/000350806
  • Smith P. J., Blumenthal J. A., Hoffman B. M., Cooper H., Strauman T. A., Welsh-Bohmer K., … Sherwood A. (2010). Aerobic exercise and neurocognitive performance: A meta-analytic review of randomized controlled trials. Psychosomatic Medicine, 72, 239–252. http://dx.doi.org/10.1097/PSY.0b013e3181d14633
  • Sommerfield A. J., Deary I. J., & Frier B. M. (2004). Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care, 27, 2335–2340. http://dx.doi.org/10.2337/diacare.27.10.2335
  • Soriguer F., Goday A., Bosch-Comas A., Bordiú E., Calle-Pascual A., Carmena R., … Vendrell J. (2012). Prevalence of diabetes mellitus and impaired glucose regulation in Spain: TheDi@bet.esStudy. Diabetologia, 55(1), 88–93. http://dx.doi.org/10.1007/s00125-011-2336-9
  • Spauwen P. J. J., Köhler S., Verhey F. R. J., Stehouwer C. D. A., & van Boxtel M. P. J. (2013). Effects of type 2 diabetes on 12-year cognitive change: Results from the Maastricht aging study. Diabetes Care, 36, 1554–1561. http://dx.doi.org/10.2337/dc12-0746
  • Subirats-Bayego E., Subirats-Vila G., & Soteras-Martínez I. (2012). Prescripción del ejercicio físico: Indicaciones, posología y efectos adversos. [Exercise prescription: Indications, dosage and side effects]. Medicina Clínica, 138(1), 18–24. http://dx.doi.org/10.1016/j.medcli.2010.12.008
  • Toro P., Degen C., Pierer M., Gustafson D., Schröder J., & Schönknecht P. (2014). Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years. European Archives of Psychiatry and Clinical Neurosciences, 264, 485–492. http://dx.doi.org/10.1007/s00406-013-0468-2
  • Trujillo A. J., & Fleisher L. K. (2013). Beyond income, access, and knowledge: Factors explaining the education gradient in prevention among older adults with diabetes and hypertension in Latin America. Journal of Aging and Health, 25, 1398–1424. http://dx.doi.org/10.1177/0898264313508190
  • van den Berg E., De Craen A. J., Biessels G. J., Gussekloo J., & Westendorp R. G. (2006). The impact of diabetes mellitus on cognitive decline in the oldest of the old: A prospective population-based study. Diabetologia, 49, 2015–2023.
  • van Harten B., Oosterman J., Muslimovic D., van Loon B. J., Scheltens P., & Weinstein H. C. (2007). Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing, 36, 164–170.
  • Ward M. A., Carlsson C. M., Trivedi M. A., Sager M. A., & Johnson S. C. (2005). The effect of body mass index on global brain volume in middle-aged adults: A cross sectional study. BMC Neurology, 5, 23. http://dx.doi.org/10.1186/1471-2377-5-23
  • Wechsler D. (2008). WAIS IV. Escala de Inteligencia de Wechsler para Adultos IV. [Wechsler Adult Intelligence Scale]. Madrid, Spain: NCS Pearson, Inc.
  • West R. L. (1996). An application of prefrontal cortex function theory to cognitive aging. Psychological Bulletin, 120, 272–292. http://dx.doi.org/10.1037/00332909.120.2.272
  • West R. (2000). In defense of the frontal lobe hypothesis of cognitive aging. Journal of the International Neuropsychological Society, 6, 727–729. http://dx.doi.org/10.1017/S1355617700666109
  • Whitmer R. A., Gustafson D. R., Barrett-Connor E., Haan M. N., Gunderson E. P., & Yaffe K. (2008). Central obesity in midlife and risk of dementia three decades later. Neurology, 71, 1057–1064. http://dx.doi.org/10.1212/01.wnl.0000306313.89165.ef
  • Whitmer R. A., Gunderson E. P., Barrett-Connor E., Quesenberry C. P. Jr., & Yaffe K. (2005). Obesity in middle age and future risk of dementia: A 27 year longitudinal population based study. British Medical Journal, 330, 1360. http://dx.doi.org/10.1136/bmj.38446.466238.E0
  • Whitmer R. A., Gunderson E. P., Quesenberry, Zhou J., & Yaffe K. (2007). Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Current Alzheimer Research, 4, 103–109. http://dx.doi.org/10.2174/156720507780362047
  • World Health Organization (2010). Global status report on noncommunicable diseases. Geneva, Switzerland: Author. Retrieved from http://www.who.int/nmh/publications/ncd_report2010/en/
  • Wysocki M., Luo X., Schmeidler J., Dahlman K., Lesser G. T., Grossman, … Beeri M. S. (2012). Hypertension is associated with cognitive decline in elderly people at high risk for dementia. American Journal of Geriatric Psychiatry, 20, 179–187. http://dx.doi.org/10.1097/JGP.0b013e31820ee833
  • Xia W., Wang S., Sun Z., Bai F., Zhou Y., Yang Y., … Yuan Y. (2013). Altered baseline brain activity in type 2 diabetes: A resting-state fMRI study. Psychoneuroendocrinology, 38, 2493–2501. http://dx.doi.org/10.1016/j.psyneuen.2013.05.012
  • Xu W. L., Qiu C. X., Wahlin A., Winblad B., & Fratiglioni L. (2004). Diabetes mellitus and risk of dementia in the Kungsholmen project. A 6-year follow-up study. Neurology, 63, 1181–1186. http://dx.doi.org/10.1212/01.WNL.0000140291.86406.D1
Fuente de los datos: Dialnet